Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
March 7, 2023
FDA Issues Draft Guidance on “External Controls” in Clinical Trials to Support Safety and Efficacy of a Drug
February 21, 2023
FTC Announces First Enforcement of the Health Breach Notification Rule
February 2, 2023
It’s Not Just for Dietary Supplements Anymore: FTC Revises and Expands Guidance for Health Claims
March 7, 2023
Erich Almonte, John Richter, Jeremy Bylund and David Mattern advise Senseonics in a qui tam case before a Texas federal court
March 6, 2023
The American Lawyer reports on the firm’s 2022
December 12, 2022
Highbridge Capital Management Closes $25 million Senior Secured Exchangeable Term Loan with Gamida Cell
October 18, 2022
Almerys group to close its first LBO